dc.contributor.author | Ononge, Sam | |
dc.contributor.author | Karamagi, Charles | |
dc.contributor.author | Nakabiito, Clemensia | |
dc.contributor.author | Wandabwa, Julius | |
dc.contributor.author | Mirembe, Florence | |
dc.contributor.author | Rukundo, Godfrey Z | |
dc.contributor.author | Jennings, Larissa | |
dc.date.accessioned | 2015-06-25T06:37:11Z | |
dc.date.available | 2015-06-25T06:37:11Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Ononge, S, et al. (2013). Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda. International Journal of Gynecology and Obstetrics,124: 235–239. | en_US |
dc.identifier.other | http://dx.doi.org/10.1016/j.ijgo.2013.08.011 | |
dc.identifier.uri | http://hdl.handle.net/10570/4481 | |
dc.description.abstract | Objective: To determine factors associated with an unknown HIV serostatus among pregnantwomen admitted in
labor to Mulago Hospital, Kampala, Uganda. Methods: In total, 665 pregnant women admitted to Mulago Hospital
were interviewed about their sociodemographic characteristics, obstetric history, access to prenatal care, fears
regarding HIV testing, and knowledge about modes of mother-to-child-transmission (MTCT). Knowledge of
the HIV serostatus was assessed by self-report and verified by prenatal card review. Results: The prevalence of unknown
HIV serostatus at the time of labor was 27.1%. Factors associated with an unknown HIV serostatus included
high parity (odds ratio [OR] 1.9; 95% confidence interval [CI], 1.16–3.14), preterm delivery (OR 2.60; 95% CI,
1.06–6.34), prenatal care at a private clinic (OR 12.87; 95% CI, 5.68–29.14), residence more than 5 km from the
nearest prenatal clinic (OR 2.86; 95% CI, 1.18–17.9), high knowledge about MTCT (OR 0.25; 95% CI, 0.07–0.86),
and fears related to disclosing the test result to the partner (OR 3.60; 95% CI, 1.84–7.06). Conclusion: The high
prevalence of unknown HIV serostatus among women in labor highlights the need to improve accessibility to
HIV testing services early during pregnancy to be able to take advantage of antiretroviral therapy. | en_US |
dc.description.sponsorship | Office of the US Global Aids Coordinator;
National Institutes of Health;
Health Resources and Service Administration. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ireland | en_US |
dc.subject | Delivery | en_US |
dc.subject | Labor | en_US |
dc.subject | Prevention of mother-to-child transmission | en_US |
dc.subject | Unknown HIV serostatus | en_US |
dc.subject | PMTCT | en_US |
dc.subject | HIV/AIDS | en_US |
dc.subject | Antiretroviral therapy | en_US |
dc.title | Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda. | en_US |
dc.type | Journal article | en_US |